Publishing: Journals, books and databases
Close Icon
Scheduled maintenance upgrade on Thursday 18 February 2016 from 10am to 12noon (GMT)
During this time you may experience an intermittent reduction in performance, with the possibility of our publishing platform services being offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.
Urgent high quality communications from across the chemical sciences.
Impact Factor 6.834 100 Issues per Year Indexed in Medline

Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

Corresponding authors
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia
Fax: +61 7 3346 3973
Tel: +61 7 3346 3283
The School of Pharmacy, The University of Queensland, Brisbane, Australia
Mucosal Diseases Group, Mater Research Institute – The University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, Australia
Chem. Commun., 2014,50, 5547-5550

DOI: 10.1039/C4CC00620H
Received 24 Jan 2014, Accepted 17 Feb 2014
First published online 17 Feb 2014
| | | | | | More
Please wait while Download options loads

Supplementary Info